Mammographic screening: A key factor in the control of breast cancer

Cancer Journal

Volumn 9, Issue 1, 2003, Pages 15-27

  Tabár, Làszló ^a   Smith, Robert A ^b   Vitak, Bedrich ^c   Yen, Ming Fang ^d,e   Chen, Tony Hsiu Hsi ^f   Warwick, Jane ^d   Myles, Jonathan P ^d   Duffy, Stephen W ^d  

^a FALUN HOSPITAL   (Sweden)

^b AMERICAN CANCER SOCIETY   (United States)

^c LINKÖPING UNIVERSITY   (Sweden)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; BREAST CARCINOMA; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SCREENING; CLINICAL TRIAL; HUMAN; MAMMOGRAPHY; MASTECTOMY; PRIORITY JOURNAL; REVIEW; BREAST TUMOR; EPIDEMIOLOGY; FEMALE; INCIDENCE; ITALY; MASS SCREENING; METHODOLOGY; RISK ASSESSMENT; SURVIVAL; SWEDEN;

BIAS (EPIDEMIOLOGY); BREAST NEOPLASMS; CLINICAL TRIALS; FEMALE; HUMANS; INCIDENCE; ITALY; MAMMOGRAPHY; MASS SCREENING; RISK ASSESSMENT; SURVIVAL ANALYSIS; SWEDEN;

EID: 0037946788     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200301000-00004     Document Type: Review

References (31)

1. Shapiro S, Strax P, Venet L. Periodic breast cancer screening in reducing mortality from breast cancer. J Am Med Assoc 1971;215:1777-1785.
2. Shapiro S. Periodic screening for breast cancer: the HIP randomized controlled trial. Monogr Natl Cancer Inst 1997;22:27-30.
3. Tabár L, Vitak B, Chen HH et al. The Swedish Two-County Trial twenty years later: updated mortality results and new insights from long-term follow-up. Radiol Clin North Am 2001;38:625-651.
4. Andersson I, Nyström L. Mammography screening. J Natl Cancer Inst 1995;87:1263-1264.
5. Frisell J, Lidbrink E, Hellstrom L et al. Follow-up after 11 years: update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 1997;45:263-270.
6. Bjurstam N, Björneld L, Duffy SW et al. The Gothenburg Breast Screening Trial: first results on mortality, incidence and mode of detection for women ages 39-49 years at randomisation. Cancer 1997;80:2091-2099.
7. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study: update on breast cancer mortality. Monogr Natl Cancer Inst 1997;22:37-41.
8. Miller AB, To T, Baines CJ et al. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000;92:1490-1499.
9. Alexander FE, Anderson TJ, Brown HK et al. 14 years of follow-up from the Edinburgh randomized trial of breast-cancer screening. Lancet 1999;353:1903-1908.
10. Kerlikowske K. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit. Monogr Natl Cancer Inst 1997;22:79-86.
11. Hendrick RE, Smith RA, Rutledge JH et al. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. Monogr Natl Cancer Inst 1997;22:87-92.
12. Gøtzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-134.
13. Olsen O, Gøtzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-1342.
14. Nixon RM, Prevost TC, Duffy SW et al. Some random effects models for the analysis of cluster randomized trials: application to the Swedish two-county trial of breast cancer screening. J Epidemiol Biostat 2000;5:349-358.
15. Tabár L, Fagerberg G, Duffy SW et al. The Swedish two-county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health 1989;43:107-114.
16. Duffy SW, Tabár L, Smith RA. The mammographic screening trials: commentary on the recent work by Olsen and Gøtzsche. CA Cancer J Clin 2002;52:68-71.
17. Tabár L, Chen HH, Duffy SW et al. Primary and adjuvant therapy, prognostic factors and survival in 1053 breast cancers diagnosed in a trial of mammography screening. Jpn J Clin Oncol 1989;29:608-616.
18. Tabár L, Duffy SW, Yen MF et al. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an endpoint. J Med Screening; in press.
19. Paci E, Duffy SW, Giorgi D et al. Are breast cancer screening programmes increasing rates of mastectomy? Observational study. Br Med J 2002;325:418.
20. Duffy SW, Tabár L, Chen HH et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties: a collaborative evaluation. Cancer 2002;95:458-469.
21. Tabár L, Vitak B, Chen HH et al. Beyond randomized controlled trials: organized mammography screening substantially reduces breast carcinoma mortality. Cancer 2001;91:1724-1731.
22. Paci E, Duffy SW, Giorgi D et al. Quantification of the effect of mammographic screening on fatal breast cancers: the Florence programme 1990-96. Br J Cancer 2002;87:65-69.
23. Tabár L, Yen MF, Vitak B et al. Mammography service screening and mortality among breast cancer cases: results of 20-year follow-up before-after introduction of screening. Lancet; submitted.
24. Duffy SW, Cuzick J, Tabár L et al. Correcting for non-compliance bias in case-control studies to evaluate screening programmes. Appl Stat 2002;51:235-243.
25. Cuzick J, Edwards R, Segnan N. Adjusting for non-compliance and contamination in randomised screening trials. Stat Med 1997;16:1017-1029.
26. Ringash J. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer. Can Med Assoc J 2001;164:469-476.
27. Törnberg S, Carstensen J, Hakulinen T et al. Evaluation of the effect on breast cancer mortality of population-based mammography screening programmes. J Med Screening 1994;1:184-187.
28. Lenner P, Jonsson H. Excess mortality from breast cancer in relation to mammography screening in northern Sweden. J Med Screening 1997;4:6-9.
29. Jonsson H, Nyström L, Törnberg S et al. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. J Med Screening 2001;8:152-160.
30. Blanks RG, Moss SM, McGahan CE et al. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. Br Med J 2000;321:665-669.
31. McCann J, Duffy SW, Day NE. Predicted long-term mortality reduction associated with the second round of breast screening in East Anglia. Br J Cancer 2001;84:423-428.